Industry News

Researchers have found a possible explanation for why many cancer drugs work in mouse models but not human, along with a new method for starving cells, and an unexpected discovery regarding transposons & blood cancers. Explore this months oncology round-up:

Explore recent news within infectious disease in our latest Industry Round Up.

This March, we’re reading about ground-breaking T-cell therapy in multiple myeloma patients, new tumor-penetrating therapy to enhance chemotherapy, and the use of nano-probes to detect cancer.

As we move into March 2021, we explore three recent findings within infectious disease as part of our monthly Industry News Round-Up.

This week, we’re looking at research on immunotherapy applications in kidney cancer, a potential prostate cancer test that could avoid unnecessary biopsies, and immunotherapy responses in various cancer treatments.

What’s new in infectious disease for January 2021? We’ve rounded up information on fast-tracking methods for vaccines within pre-clinical tests, the presence of water molecules in drug-resistant bacteria models, and a hopeful vaccination against Staphylococcus infections.

What’s new in oncology this January? We’ve rounded up information on the use of cancer microbiomes in tumors, an inhibitor drug combination for a rare form of cancer, and new clues to prostate cancer.

What’s new in infectious disease as we kick off 2021? We’ve rounded up information on new functions for malaria parasites, adaptive genome evolution, and COVID-19’s effect on human airway organoids.

Driving factors that lead to cancer spread in the brain, magnetic bacteria in oncology research, and immune boosting therapy — we’ve rounded up interesting oncology news for December 2020.

As we round out November 2020, we’re reading about a successful COVID-detecting AI model, a promising relationship between the MMR vaccine & COVID-19, and a new study behind the causes of fatal influenza.